Merck appoints Kai Beckmann as Chair of Executive Board and CEO
He will succeed Belén Garijo, and take charge from May 1, 2026
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Lupin gets tentative US FDA nod for Bictegravir, Emtricitabine, and Tenofovir Alafenamide tablets
They are indicated for the treatment of human immunodeficiency virus infection in adults and pediatric patients weighing at least…
FDA’s curb on overseas cell processing to hit smaller cell and gene therapy companies:…
Regulators haven’t specified how many trials are affected, though therapies like CAR-T, which sometimes use overseas manufacturing…
Alembic Pharma gets EIR for its API – I & API – II facility located at Panelav
USFDA had carried out the inspection between May 26 – May 31, 2025
Shree Ramkrishna Exports Group launches Kriam Pharma
Kriam Pharma will focus on categories such as anti-diabetic, cardiac care, gastrointestinal, pain management, dermatology,…
AstraZeneca launches Eculizumab in India
It is now the first anti-complement therapy authorised in India for the treatment of for atypical Haemolytic Uremic Syndrome(aHUS)…
Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA
The acquisition will be funded through the IPO proceeds raised by Senores. This is in line with the Objects of the IPO stated in…
Global pharma deal value rises to $18.3 billion in July 2025: GlobalData
Merck, Nordic Capital, and Sanofi drive 79 per cent of July’s total deal value as venture capital activity records a decline
Medistep Healthcare eyes ₹16.09 cr fundraise to acquire new plant & machinery
A significant portion of the IPO proceeds will be allocated toward the acquisition and installation of advanced equipment at the…
Startups: India’s next big bet on pharma innovation?
While India’s pharma startups can resolve scientific and systemic blind spots, funding remains the missing link blocking scalable…
India’s pharma funding reaches $294 million in July 2025
Pharma funding snapshot highlights late-stage dominance and surge in capital flow, with Meril’s $200M round leading July’s…
US-EU trade deal puts pharma industry at substantial fiscal risk: GlobalData
The imposition of tariffs threatens to elevate costs, creating uncertainty in launch planning, particularly for late-stage assets…
China’s obesity market forecasts rise with homegrown therapies and late-stage pipeline
With ten other drugs in Phase III development by domestic companies, according to GlobalData’s Pharmaceutical Intelligence Center,…
Top 20 biopharma companies see 7.9% increase in aggregate revenue in 2024: GlobalData
Seven out of the top 20 companies registered over 10 per cent YoY revenue growth from 2023 to 2024
PharmNXT acquires DTR, brings European bioprocess engineering to India
This move enables PharmNXT to access technology solutions related to single-use systems
Pfizer completes licensing agreement with 3SBio
The agreement allows Pfizer to manufacture and commercialise 3SBio’s SSGJ-707, a bispecific antibody targeting PD-1 and VEGF…
Kilitch Drugs to raise around ₹50 crore via rights issue at Rs. 375 per share
The issue is expected to raise ₹4,992.51 lakh, which will be utilised to strengthen the company’s balance sheet, support growth…
NATCO Pharma offers to acquire stake in South African Adcock Ingram Holdings
Adcock Ingram generated revenue of R9.6 billion ($ 536 million*) in the financial year June’24 and delivered a gross margin of…
Akums launches high-strength Paracetamol Oral Suspension 500mg/5ml
This novel oral suspension is an addition to the analgesic and antipyretic category by offering therapeutic adult dosing in a…
Cipla invests in iCaltech Innovations to strengthen respiratory play
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core…